Phoenix Children’s Medical Connection
Welcome to Phoenix Children’s Medical Connection. Here you will find the latest in research, clinical innovation and continuing medical education from Phoenix Children’s experts. We hope you find this resource helpful to you and your practice; we invite you to come back often to stay abreast of the latest developments.
The content on this website is intended for physicians. Patients, please visit phoenixchildrens.org to learn more about our services for patients.
Specialties
Choose a specialty to view the latest content
Recently Added
International Consensus on the Evaluation and Management of : Results From a Modified Delphi Survey
Hypothalamic hamartomas (HH) are rare developmental brain lesions frequently associated with medically refractory epilepsy and complex neurobehavioral, cognitive and endocrine comorbidities.
De Novo Variants in the Splicing Factor Gene SF3B1 Are Associated with Neurodevelopmental Disorders
Constitutional variants in the splicing factor SF3B1 have been linked to neurodevelopmental disorders for the first time, according to a new multinational study co-authored by Phoenix Children’s Pediatric Neurologist and Neurogeneticist Michael ...
American Epilepsy Society Clinical Practice Guideline: Infantile Epilepsy
This American Epilepsy Society (AES) practice guideline provides updated, evidence-based recommendations for the management of epilepsy in infants and children aged 1 month to <36 months.
Phoenix Children’s Joins First Controlled Clinical Trial of Genetic Therapy for Dravet Syndrome
The first controlled phase 3 trial of a genetic therapy for Dravet syndrome is now underway – with Phoenix Children's as one of 28 sites nationwide.

